Design: multicentre randomised controlled trial, 2:1, assessor-masked
Population: 410 German women with stage I–III lipoedema and leg pain ≥4/10, mean age 42.9 years
Primary outcome: reduction in patient-reported leg pain of at least 2 points at 12 months
Effect: 68% vs 8%, odds ratio 26.2 (95% CI 13.1–52.5), p<0.0001; serious adverse events 8% vs 3%

Lipoedema is a painful disorder of subcutaneous adipose tissue, almost always in women, and it is routinely mistaken for obesity or lymphoedema. Complex decongestive therapy is the standard of care, and this trial is the first randomised test of whether surgery does better. At 11 German centres, 410 women with stage I to III lipoedema and leg pain of at least 4 on a 0–10 scale — all of whom had already had up to seven months of conservative therapy — were randomised two to one to liposuction or continued conservative treatment. Assessors were masked by applying patches to every patient's legs.

At 12 months, 190 of 278 in the liposuction group (68%) achieved the primary endpoint of at least a two-point pain reduction, against 10 of 132 (8%) on conservative therapy — odds ratio 26.2 (95% CI 13.1 to 52.5). Quality of life improved more with surgery. The harms are not trivial: adverse events occurred in 47% of surgical patients with 8% rated serious, against 21% and 3% with conservative care. Follow-up to 36 months is still running.

The immediate use for a generalist is diagnostic rather than surgical. Women with disproportionate, tender, non-pitting leg fat that does not respond to weight loss are frequently told the problem is their weight; this trial establishes that the condition has a treatment with a large effect. Whether liposuction is affordable or accessible is a separate question, and in India it is largely a self-funded cosmetic-coded procedure, which is worth saying plainly rather than implying a pathway that does not exist.

Consider lipoedema in a woman with symmetrical, painful, non-pitting leg fat sparing the feet
Document the pain score — the trial's threshold was 4 or more out of 10, and the endpoint a two-point fall
Explain that about one in twelve operated patients had a serious adverse event
Do not offer surgery as a first step: every trial patient had already completed conservative therapy
Be direct about cost and coding in Indian practice rather than implying insurance cover

Why it matters

A condition routinely dismissed as obesity turns out to have a treatment that works, which changes what a referral is for.

The statistics, in plain English

An odds ratio of 26.2 looks extraordinary, and the reason is that the comparator almost never worked: only 8% of conservative patients reached the threshold. When the control event rate is very low, the ratio inflates even though the absolute gain — 68% against 8%, so 60 percentage points — is the number that matters. Note also that patients could not be blinded to whether they had surgery, and the endpoint is self-reported pain, which is exactly the combination in which expectation inflates an effect.